FK-866 has been shown to induce apoptosis by non-competitive, and specific inhibition of nicotamide phosphoribosyltransferase (NAMPT). NAMPT is a key regulatory enzyme that mediates NAD+ biosynthesis within cells. Mechanistic studies show that this compound contains an enzymatic active site of visfatin which is optimized for nicotinamide binding and inhibition. Visfatin also contains a similar structure to insulin and mimics its actions by binding to the insulin receptors.
For Research Use Only
References
. Hasmann, M. and Schemainda, I. 2003. Cancer Res. 63: 7436-7442. PMID: 14612543
2. Kim, M.K., et al. 2006. J. Mol. Biol. 362: 66-77. PMID: 16901503
3. van der Veer, E., et al. 2007. J. Biol. Chem. 282: 10841-10845. PMID: 17307730
4. Billington, R.A., et al. 2008. Autophagy. 4: 385-387. PMID: 18227641
